The longer the drug development process, the more expensive a failure. AstraZeneca expects a server farm to speed up target discovery.

When Astra and Zeneca merged in 1999, Simon Weston got stuck dealing with the extra traffic. Weston manages the company’s Alderley Edge, UK, bioinformatics service for 1,000 scientists who analyze blood cells of patients with oncological and gastrointestinal diseases. Their work entails running a series of bioinformatics applications on public sequence data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.